It was a tough call as import of these low-cost key active pharmaceutical ingredients (APIs), or raw materials - almost entirely from China - was helping Indian formulation companies, or entities that make syrups, tablets, injections, etc, remain competitive. An increase in medicine prices due to rise in input ...
Read more: Drug Wars